GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cosmo Bio Co Ltd (TSE:3386) » Definitions » EV-to-FCF

Cosmo Bio Co (TSE:3386) EV-to-FCF : (As of May. 22, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Cosmo Bio Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Cosmo Bio Co's Enterprise Value is 円2,884 Mil. Cosmo Bio Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was 円0 Mil. Therefore, Cosmo Bio Co's EV-to-FCF for today is .

The historical rank and industry rank for Cosmo Bio Co's EV-to-FCF or its related term are showing as below:

TSE:3386' s EV-to-FCF Range Over the Past 10 Years
Min: -51.08   Med: -46.27   Max: 13.49
Current: 4.55

During the past 13 years, the highest EV-to-FCF of Cosmo Bio Co was 13.49. The lowest was -51.08. And the median was -46.27.

TSE:3386's EV-to-FCF is ranked better than
86.73% of 98 companies
in the Medical Diagnostics & Research industry
Industry Median: 27.265 vs TSE:3386: 4.55

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-22), Cosmo Bio Co's stock price is 円973.00. Cosmo Bio Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was 円69.964. Therefore, Cosmo Bio Co's PE Ratio for today is 13.91.


Cosmo Bio Co EV-to-FCF Historical Data

The historical data trend for Cosmo Bio Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cosmo Bio Co EV-to-FCF Chart

Cosmo Bio Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.10 6.14 7.35 19.03 5.21

Cosmo Bio Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 5.21 -

Competitive Comparison of Cosmo Bio Co's EV-to-FCF

For the Diagnostics & Research subindustry, Cosmo Bio Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cosmo Bio Co's EV-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Cosmo Bio Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Cosmo Bio Co's EV-to-FCF falls into.



Cosmo Bio Co EV-to-FCF Calculation

Cosmo Bio Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=2884.374/0
=

Cosmo Bio Co's current Enterprise Value is 円2,884 Mil.
Cosmo Bio Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cosmo Bio Co  (TSE:3386) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Cosmo Bio Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=973.00/69.964
=13.91

Cosmo Bio Co's share price for today is 円973.00.
Cosmo Bio Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円69.964.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Cosmo Bio Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Cosmo Bio Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Cosmo Bio Co (TSE:3386) Business Description

Traded in Other Exchanges
N/A
Address
2-20, Toyo-Ekimae Building, Toyo 2-Chome, Koto-ku, Tokyo, JPN, 135-0016
Cosmo Bio Co Ltd is a diagnostic and research company based in Japan. The business of the company includes purchase of reagents, instruments, clinical test drugs for research on life science and domestic sales.

Cosmo Bio Co (TSE:3386) Headlines

No Headlines